| |
Goals |
|
1. Exchange Information |
2. Identify and Develop Priorities |
3. Coordinate Efforts |
| |
Objectives |
|
1.1 Rapidly disseminate new data and information developed by participating agencies |
2.1 Identify and evaluate promising vaccine strategies |
3.1 Identify and monitor ongoing and future R&D approaches |
1.2 Monitor developments in malaria vaccine R&D efforts outside of the Federal Government |
2.2 Identify and elaborate critical pathways for product development and evaluation |
3.2 Identify and review potential or perceived duplications of efforts |
1.3 Provide informed and coordinated responses to requests for information and opinions |
2.3 Identify and address critical technical obstacles and resource limitations |
3.3 Encourage and facilitate high-level interactions among departments and agencies to improve coordination of efforts |
1.4 Inform and advise members about manufacturing, production, regulatory, clinical testing, and implementation issues |
2.4 Advise participating agencies regarding milestones and endpoints for product development, evaluation, and implementation |
3.4 Propose, facilitate and monitor new collaborative efforts |
| |
2.5 Advise funding agencies of areas requiring increased emphasis |
3.5 Encourage greater participation in malaria vaccine development by the non-Federal sector |
